Haller Julia A
Insider CIK 1656082 · BMY Director · OTLK Director · EYEN Director · CELG Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2026-06-15 | 2026-06-16 | 20,460 | — | $0 | 0 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2026-06-15 | 2026-06-16 | 20,460 | $53.76 | $1.10M | 34,079 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2026-02-01 | 2026-02-03 | 3,996 | $55.05 | $220.0K | 37,903 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2025-10-03 | 2025-10-03 | 58,648 | — | $0 | 58,648 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2025-10-01 | 2025-10-03 | 286,734 | — | $0 | 286,734 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2025-02-01 | 2025-02-04 | 3,562 | $58.95 | $210.0K | 32,223 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2024-10-03 | 2024-10-03 | 12,082 | — | $0 | 12,082 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2024-10-01 | 2024-10-03 | 56,636 | — | $0 | 56,636 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2024-10-01 | 2024-10-03 | 47,232 | — | $0 | 47,232 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2024-03-07 | 2024-03-08 | 94,441 | — | $0 | 94,441 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2024-02-01 | 2024-02-05 | 4,315 | $48.67 | $210.0K | 27,341 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2023-12-31 | 2024-01-03 | 706 | $51.31 | $36.3K | 22,746 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2023-10-04 | 2023-10-05 | 210,225 | — | $0 | 210,225 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2023-09-30 | 2023-10-03 | 625 | $58.04 | $36.3K | 21,797 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2023-06-30 | 2023-07-05 | 554 | $63.95 | $35.4K | 20,978 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2023-03-31 | 2023-04-04 | 487 | $69.31 | $33.7K | 20,256 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2023-03-29 | 2023-03-31 | 41,065 | — | $0 | 41,065 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2023-02-01 | 2023-02-03 | 2,808 | $71.23 | $200.0K | 19,769 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2022-12-31 | 2023-01-04 | 469 | $71.95 | $33.8K | 16,826 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2022-10-05 | 2022-10-07 | 42,239 | — | $0 | 42,239 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2022-09-30 | 2022-10-04 | 475 | $71.09 | $33.7K | 16,244 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2022-08-11 | 2022-08-15 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2022-06-30 | 2022-07-05 | 438 | $77.00 | $33.7K | 15,655 | SEC↗ |
| EYEN EYENOVIA, INC. | A Award deriv | 2022-06-16 | 2022-06-21 | 30,769 | — | $0 | 30,769 | SEC↗ |
| EYEN EYENOVIA, INC. | A Award | 2022-06-16 | 2022-06-21 | 22,222 | — | $0 | 30,408 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2022-06-03 | 2022-06-07 | 2,949 | — | $0 | 0 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2022-06-03 | 2022-06-07 | 2,949 | — | $0 | 13,619 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2022-03-31 | 2022-04-04 | 462 | $73.03 | $33.8K | 15,108 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2022-02-01 | 2022-02-03 | 3,068 | $65.19 | $200.0K | 14,646 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2021-12-31 | 2022-01-04 | 521 | $62.35 | $32.5K | 11,482 | SEC↗ |
| EYEN EYENOVIA, INC. | A Award deriv | 2021-11-17 | 2021-11-22 | 9,653 | — | $0 | 9,653 | SEC↗ |
| EYEN EYENOVIA, INC. | A Award | 2021-11-17 | 2021-11-22 | 6,963 | — | $0 | 8,186 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2021-09-30 | 2021-10-01 | 549 | — | $0 | 10,870 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2021-06-30 | 2021-07-01 | 487 | — | $0 | 10,247 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2021-06-13 | 2021-06-14 | 902 | — | $0 | 0 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2021-06-13 | 2021-06-14 | 902 | — | $0 | 10,670 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2021-06-03 | 2021-06-04 | 2,949 | — | $0 | 2,949 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2021-06-03 | 2021-06-04 | 2,949 | — | $0 | 9,768 | SEC↗ |
| EYEN EYENOVIA, INC. | A Award deriv | 2021-03-31 | 2021-04-01 | 1,637 | — | $0 | 1,637 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2021-03-31 | 2021-04-02 | 515 | $63.13 | $32.5K | 9,690 | SEC↗ |
| EYEN EYENOVIA, INC. | A Award | 2021-03-31 | 2021-04-01 | 1,223 | — | $0 | 1,223 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2021-02-01 | 2021-02-03 | 3,054 | $62.21 | $190.0K | 9,175 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2020-12-31 | 2021-01-05 | 524 | $62.03 | $32.5K | 6,073 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2020-09-30 | 2020-10-02 | 539 | $60.29 | $32.5K | 5,507 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2020-06-30 | 2020-07-02 | 529 | $58.80 | $31.1K | 4,931 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2020-06-14 | 2020-06-16 | 558 | — | $0 | 0 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2020-06-14 | 2020-06-16 | 558 | — | $0 | 6,819 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2020-06-13 | 2020-06-16 | 903 | — | $0 | 902 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2020-06-13 | 2020-06-16 | 903 | — | $0 | 6,261 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2020-06-03 | 2020-06-05 | 2,949 | — | $0 | 5,898 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2020-06-03 | 2020-06-05 | 2,949 | — | $0 | 5,358 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2020-03-31 | 2020-04-02 | 516 | $55.74 | $28.8K | 4,369 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2020-02-01 | 2020-02-04 | 3,018 | $62.95 | $190.0K | 3,853 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-12-31 | 2020-01-03 | 178 | $64.19 | $11.4K | 834 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 13,266 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 970 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 300 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 4,756 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 10,500 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 11,000 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 10,000 | — | $0 | 0 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-11-20 | 2019-11-22 | 656 | $56.41 | $37.0K | 656 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-11-20 | 2019-11-27 | 24,674 | — | $0 | 24,674 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-11-20 | 2019-11-27 | 1,805 | — | $0 | 1,805 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-11-20 | 2019-11-27 | 558 | — | $0 | 558 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-11-20 | 2019-11-27 | 8,847 | — | $0 | 8,847 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-11-20 | 2019-11-27 | 19,635 | — | $0 | 19,635 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-11-20 | 2019-11-27 | 20,460 | — | $0 | 20,460 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-11-20 | 2019-11-27 | 18,700 | — | $0 | 18,700 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer | 2019-11-20 | 2019-11-22 | 2,409 | — | $0 | 0 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award | 2019-11-20 | 2019-11-27 | 2,409 | — | $0 | 2,409 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2019-06-15 | 2019-06-17 | 375 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2019-06-15 | 2019-06-17 | 375 | — | $0 | 2,409 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2019-06-14 | 2019-06-17 | 300 | — | $0 | 300 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2019-06-14 | 2019-06-17 | 300 | — | $0 | 2,034 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2019-06-13 | 2019-06-17 | 484 | — | $0 | 970 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2019-06-13 | 2019-06-17 | 484 | — | $0 | 1,734 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2019-06-03 | 2019-06-05 | 4,756 | — | $0 | 4,756 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2018-06-15 | 2018-06-15 | 375 | — | $0 | 375 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2018-06-15 | 2018-06-15 | 375 | — | $0 | 1,250 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2018-06-14 | 2018-06-15 | 300 | — | $0 | 600 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2018-06-14 | 2018-06-15 | 300 | — | $0 | 875 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2018-06-13 | 2018-06-15 | 13,266 | — | $0 | 13,266 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2018-06-13 | 2018-06-15 | 1,454 | — | $0 | 1,454 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2017-06-15 | 2017-06-16 | 375 | — | $0 | 750 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2017-06-15 | 2017-06-16 | 375 | — | $0 | 575 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2017-06-14 | 2017-06-16 | 900 | — | $0 | 900 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2017-06-14 | 2017-06-16 | 10,500 | — | $0 | 10,500 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2016-06-15 | 2016-06-17 | 1,125 | — | $0 | 1,125 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2016-06-15 | 2016-06-17 | 11,000 | — | $0 | 11,000 | SEC↗ |